E-Q. Chen West China Hospital of Sichuan University Chengdu (China)
Dr. En-Qiang Chen has graduated from Sichuan University( Chengdu, China) and served as
Associate professor in Center of Infectious Diseases, West China Hospital of Sichuan University.
He has published more than 50 full peer reviewed publications, 8 book chapters, 15 presentations
at international meetings, 2 peer reviewed funded grants and 1 authorized patent. In recent years,
he has focused on the basic and clinical research of stem cells in the treatment of liver diseases.
I. Chimenti "La Sapienza" University of Rome Rome (Italy)
Isotta Chimenti is Assistant Professor at the Department of Medical Surgical Sciences and
Biotechnologies, Faculty of Pharmacy and Medicine, and Junior Fellow of the Superior
School for Advanced Studies at “La Sapienza” University of Rome. She is eligible as
Associate Professor, according to the Italian National Scientific Qualification program. Her
education includes a Master of Science in Medical Biotechnology, and a PhD in
Experimental Medicine. She has been a postdoc fellow at Johns Hopkins University, at
Cedars Sinai Heart Institute, and at Pasteur Institute – Italy. Her research activity is
focused on regenerative medicine, in particular on cardiac cell therapy and cardiac tissue
engineering, adult stem cells, and oxidative stress in the cardiovascular system. She is
funded as PI by several Italian National grants, and participant in a European Horizon
2020 project. She co-authored over 55 Scopus indexed publications.
Y.-M. Feng Capital Medical University Beijing (China)
Ying-Mei Feng is a Professor at Capital Medical University in Beijing, China. Currently, she is also the deputy director of the Science and Technology Department at Capital Medical University. She received her medical degree from Tian Jin Medical University in China. After three years of residency in Neurology, she went to Belgium to pursue research. She received her Ph.D. degree in Medical Science at Leuven University in Belgium in 2008. Her main research interest is to understand the pathogenesis of vascular complications in diabetes and cardiovascular disease. She has published more than 40 papers in peer-reviewed journals including Blood, Arteriosclerosis, Thrombosis and Vascular Biology and Stem Cells. She has been on the editorial board of Plos One and Current Stem Cell Research & Therapy and served as a guest editor for Stem Cell International and Current Gene Therapy, respectively.
Y. Lv Chongqing University Chongqing (China)
Yonggang Lv received the Ph.D. degree in Refrigeration and Cryogenic Engineering
with specialty in bioengineering from the Technical Institute of Physics and
Chemistry, Chinese Academy of Science, Beijing, in 2005. He served as a
postdoctoral research associate/research fellow at the City College of the City
University of New York and Memorial Sloan-Kettering Cancer Center. He joined the
Bioengineering College at Chongqing University as Full Professor in March 2009 and
won the Program for New Century Excellent Talents in University, Ministry of
Education of China in 2010. He became a senior visiting scholar in Prof. Shu Chien’s
laboratory at University of California, San Diego (UCSD) from July to October 2014.
He has published over 100 peer referred journal papers, edited 3 books, and holds 9
China patents. His research interests include mechanobiology and regenerative
medicine, stem cell biology, and cancer biology.
Dr. Lv is the Vice Chairman of hemorheology committee in Chinese Society of
Microcirculation. He is an associate editor of Medical & Biological Engineering &
Computing and an editorial member of Biotechnology Letters.
James J. Yoo (14898 citations) Wake Forest University School of Medicine Winston-Salem, NC (USA)
Dr. Yoo is a Professor, Associate Director and Chief Scientific Officer at the Wake Forest Institute for Regenerative Medicine (WFIRM), and is cross-appointed to the Departments of Urology, Physiology and Pharmacology and Biomedical Engineering. Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo's background in cell biology and medicine has facilitated the transfer of several cell-based technologies from the bench-top to the bedside. A few notable examples of successful clinical translation include the bladder, urethra, vagina, and muscle cell therapy for incontinence.